Skip to content

To see the effect of ayurvedic medicated ghee nasal drops in headache

An open label two armed prospective randomized controlled phase II clinical study to evaluate the efficacy of Brahmi ghrut nasya in the management of Migraine Ardhavbhedak - Nil

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/12/098809
Enrollment
70
Registered
2025-12-10
Start date
Unknown
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G508- Other disorders of trigeminal nerve

Interventions

None listed

Sponsors

Ayurved Seva Sangh Ayurved Mahavidyalaya Nashik
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Adult individuals aged 18 50 years Diagnosed with Migraine Ardhavbhedhak according to ICHD3 criteria migraine is characterized by recurrent headache attacks lasting 4 72 hours with at least two of the following unilateral location pulsating quality moderate or severe pain, and aggravation by or causing avoidance of routine physical activity At least 2 4 episodes of migraine per month for the last 3 months Able to provide written informed consent

Exclusion criteria

Exclusion criteria: Pregnant or lactating women History of any significant neurological disorders other than migraine Any other chronic medical conditions eg cardiovascular renal hepatic disease Ongoing use of other migraine-specific treatments or herbal therapies during the study

Design outcomes

Primary

MeasureTime frame
Change in Monthly Migraine Days MMD baseline Day 30 Difference in number of migraine days in 28 day run in baseline vs days 1 30 end of treatment Timepoint: 30 days

Secondary

MeasureTime frame
50% Responder Rate at Day 30 proportion with 50% reduction in MMD vs baseline Change in Headache Intensity mean change in NRS (0 10) for migraine attacksnbaseline Day 30 Rescue Medication Use change in number of acute medication doses taken in 30 days vs baseline month Timepoint: 30 days

Countries

India

Contacts

Public ContactDr Adeeba asad

Ayurved Seva Sangh Ayurved Mahavidyala, Ganeshwadi ,Panchavati ,Nashik- 03

asadadeeba77@gmail.com9696191148

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026